Q4 2024 Myomo Inc Earnings Call Transcript
Key Points
- Myomo Inc (MYO) achieved record financial and operating results in Q4 2024, with revenues reaching $12.1 million, a 154% increase from the prior year.
- The company successfully expanded its market access by securing Medicare Part B coverage for the MyoPro powered arm brace, allowing them to serve a larger patient base.
- Myomo Inc (MYO) trained 160 certified prosthetist orthotists, surpassing their goal of 100, which is expected to drive future growth through the O&P channel.
- The international business, particularly in Germany, performed well, generating over $1 million in profitable revenue in Q4 and over $4 million for the full year.
- The company achieved positive adjusted EBITDA for the first time in its history, marking a significant financial milestone.
- Myomo Inc (MYO) continues to face challenges with Medicare Advantage and other commercial payers, with many patients being denied coverage for the MyoPro.
- The appeals process for denied claims remains slow, often requiring escalation to administrative law judge hearings, which can delay revenue recognition.
- Operating expenses increased by 60% in Q4 2024 compared to the prior year, driven by higher headcount and R&D expenses.
- Despite the growth, the company anticipates negative cash flows in the first three quarters of 2025 due to increased advertising expenses and incentive compensation payments.
- The cost per pipeline add increased, and there is uncertainty about maintaining the efficiency of marketing spend in the future.
Good afternoon, and welcome to the Myomo fourth-quarter 2024 earnings conference call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Tirth Patel. Please go ahead.
Thank you, operator, and good afternoon, everyone. This is Tirth Patel with Alliance Advisors IR. Welcome to the Myomo fourth quarter and full year 2024 conference call.
With me on today's call are Myomo's Chief Executive Officer, Paul Gudonis; and Chief Financial Officer, Dave Henry.
Before we begin, I'd like to caution listeners that statements made during this conference call by management other than historical facts are forward-looking statements. The words anticipate, believe, estimate, expect, intend, guidance, outlook, confidence, target, project, and other similar expressions are typically used to identify such forward-looking statements.
These forward-looking statements are not guarantees of future performance and may involve and are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
